Literature DB >> 3082345

The pharmacokinetics of R- and S-tocainide in patients with acute ventricular arrhythmias.

A H Thomson, G Murdoch, A Pottage, A W Kelman, B Whiting, W S Hillis.   

Abstract

The pharmacokinetics of R(-) and S(+)- tocainide were studied in twelve patients requiring intravenous tocainide. In all patients, a progressive increase in the S(+):R(-) ratio was observed during the infusion. Mean +/- s.d. ratios increased from 1.03 +/- 0.05 at 2 min to 1.76 +/- 0.35 at 48.5 h. Data from eight patients were fitted to a two-compartment model and there was a significant difference (Wilcoxon matched-pairs test P less than 0.01) in the clearance estimates for the two enantiomers. The median values were: S(+)-tocainide = 6.25 l h-1 and R(-)-tocainide = 9.31 l h-1. There was no differences in V1 or Vss.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082345      PMCID: PMC1400923          DOI: 10.1111/j.1365-2125.1986.tb05169.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man.

Authors:  A Breckenridge; M Orme; H Wesseling; R J Lewis; R Gibbons
Journal:  Clin Pharmacol Ther       Date:  1974-04       Impact factor: 6.875

2.  Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology.

Authors:  E J Ariëns
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 3.  Serum tocainide enantiomer concentrations in human subjects.

Authors:  A J Sedman; J Gal; W Mastropaolo; P Johnson; J D Maloney; T P Moyer
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

4.  Kinetics of the oral antiarrhythmic lidocaine congener, tocainide.

Authors:  D Lalka; M B Meyer; B R Duce; A T Elvin
Journal:  Clin Pharmacol Ther       Date:  1976-06       Impact factor: 6.875

5.  Disposition of (R,S)-tocainide. Some stereoselective aspects.

Authors:  J Gal; T A French; T Zysset; P E Haroldsen
Journal:  Drug Metab Dispos       Date:  1982 Jul-Aug       Impact factor: 3.922

6.  Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery.

Authors:  J Morganroth; I P Panidis; S Harley; J Johnson; E Smith; H MacVaugh
Journal:  Am J Cardiol       Date:  1984-12-01       Impact factor: 2.778

7.  Monitoring of S- and R-tocainide in human plasma after heptafluorobutyrylation, separation on Chirasil-Val and electron-capture detection.

Authors:  A M Antonsson; O Gyllenhaal; K Kylberg-Hanssen; L Johansson; J Vessman
Journal:  J Chromatogr       Date:  1984-06-08

Review 8.  Tocainide. A review of its pharmacological properties and therapeutic efficacy.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546

9.  Tocainide conjugation in humans: novel biotransformation pathway for a primary amine.

Authors:  A T Elvin; J B Keenaghan; E W Byrnes; P A Tenthorey; P D McMaster; B H Takman; D Lalka; C V Manion; D T Baer; E M Wolshin; M B Meyer; R A Ronfeld
Journal:  J Pharm Sci       Date:  1980-01       Impact factor: 3.534

10.  New antiarrhythmic agents. 1. Primary alpha-amino anilides.

Authors:  E W Byrnes; P D McMaster; E R Smith; M R Blair; R N Boyes; B R Duce; H S Feldman; G H Kronberg; B H Takman; P A Tenthorey
Journal:  J Med Chem       Date:  1979-10       Impact factor: 7.446

View more
  6 in total

Review 1.  Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs.

Authors:  Reza Mehvar; Dion R Brocks; Majid Vakily
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  New concepts affecting the use of antiarrhythmic agents.

Authors:  R L Woosley
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

3.  Stereoselective drug disposition: potential for misinterpretation of drug disposition data.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

Review 4.  Chirality in new drug development. Clinical pharmacokinetic considerations.

Authors:  R L Nation
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

5.  Stereoselective pharmacokinetics of tocainide in human uraemic patients and in healthy subjects.

Authors:  K M McErlane; J Axelson; R Vaughan; C R Kerr; J D Price; L Igwemezie; G Pillai
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  Pharmacological importance of stereochemical resolution of enantiomeric drugs.

Authors:  M R Islam; J G Mahdi; I D Bowen
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.